Medscope Biotech Co., Ltd.

Medscope Biotech Co., Ltd. Medscope develops and manufactures medical instrument in Taiwan. Our purpose is to minimize the risk during Minimally Invasive Surgery(MIS).

Our very first product is SOLID CLIP applier. It's the best occlusion solution for Laparoscopic Operation.

Introduction & Training of SOLID CLIP 5mm Single Use Clip Applier:
30/05/2023

Introduction & Training of SOLID CLIP 5mm Single Use Clip Applier:

** Reminder: Please refer to the manual in the package for proper operating instructions. **The contents of the manual include:1. Product Introduction2. Purp...

Medscope will join AORN global surgical conference expo 2023We are looking forward to meeting you there. Date: 1 April -...
28/03/2023

Medscope will join AORN global surgical conference expo 2023
We are looking forward to meeting you there.
Date: 1 April - 4 April, 2023
Venue: San Antonio, TX, USA
Booth No.: 313
https://www.aorn.org/surgical-expo
For any further information or meeting arrangement, please email to:
globalsales@medscope.com.tw

Medscope will join MEDICA Trade Fair 2022.We are looking forward to meeting you there.  # Date: November 14th to 17th # ...
20/10/2022

Medscope will join MEDICA Trade Fair 2022.
We are looking forward to meeting you there.

# Date: November 14th to 17th
# Venue: Düsseldorf Exhibition Centre
# Booth No.: 5B33-3 (Hall 5)
https://www.medica-tradefair.com/

For any further information or meeting arrangement, please email to: globalsales@medscope.com.tw

Announcement: Latest Medscope MIS Product Line-up.
09/06/2022

Announcement: Latest Medscope MIS Product Line-up.

🌟投資快報🌟【邁斯科生醫 獲日本大和證券集團旗下之Daiwa PI Partners Co. Ltd.與其合作夥伴AXR Group投資】長期深耕於微創手術(MIS)醫療器材領域,並擁有ISO-13485與GMP等認證的 邁斯科生醫股份有限...
29/12/2021

🌟投資快報🌟
【邁斯科生醫 獲日本大和證券集團旗下之Daiwa PI Partners Co. Ltd.與其合作夥伴AXR Group投資】
長期深耕於微創手術(MIS)醫療器材領域,並擁有ISO-13485與GMP等認證的 邁斯科生醫股份有限公司,近日獲得日本大和證券集團旗下之Daiwa PI Partners Co. Ltd.與其合作夥伴AXR Group對邁斯科生醫的共同投資,為雙方繼Staples Taiwan之後在台灣的第二件聯合收購案。
邁斯科生醫專注於一次性拋棄式微創手術醫材研發製造(衛部醫器製字第006655號),擁有全球多個國家和地區的技術專利,以自有品牌與代工並行進軍歐洲、中東、南非、印度等先進及新興市場,積極布建全球營銷網絡。這次獲得Daiwa PI Partners Co. Ltd.的投資,不難看出其專業的技術、國際性的布局,及未來在相關領域的發展潛力已獲得國際投資機構的高度認可。
邁斯科生醫董事長劉宏鎰表示,自2017年以來邁斯科生醫一直致力於研發和製造更安全、更高效的醫療器材,尤其是在微創手術領域。他說,即使COVID-19大流行期間,邁斯科生醫仍然能夠向歐洲、亞洲、非洲、大洋洲、中東等許多國家及地區分銷產品。
邁斯科生醫目前已在全球38個國家和地區獲得專利,生產的微創手術醫材得到經銷商和醫院KOL的廣泛認可和高度評價。劉宏鎰說,在全球醫材市場隨著人口老化及醫療技術的進步,微創手術相關醫材的需求成長快速,產業未來將蓬勃發展。未來邁斯科生醫將與日方積極合作強化經營效益,提升企業價值,偕手共創更好的明天。
中時新聞網連結:https://www.chinatimes.com/....../20211223000369......
工商時報連結:
https://readers.ctee.com.tw/cm/20211223/a44ac8/1162066/share

Address

2F, No. 8, Keyi Street, GuangYuan Technology Park, Zhunan Town, Miaoli County Taiwan, ROC
Zhunan
350

Opening Hours

Monday 09:00 - 17:30
Tuesday 09:00 - 17:30
Wednesday 09:00 - 17:30
Thursday 09:00 - 17:30
Friday 09:00 - 17:30

Telephone

+88637580055

Alerts

Be the first to know and let us send you an email when Medscope Biotech Co., Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Medscope Biotech Co., Ltd.:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram